Contact
 

Statement of Larry Corey, MD on the Success of the CAPRISA 004 Microbicide Trial

The HIV Vaccine Trials Network (HVTN) issued a statement on the CAPRISA 004 microbicide trial.  The full statement is below.

AttachmentSize
Corey 20 July.pdf59.85 KB
Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account